In an era marked by remarkable advancements in medical diagnostics, the global minimal residual disease (MRD) testing market is poised for unprecedented growth. Projections suggest that by 2031, the ...

Europe’s minimal residual disease (MRD) testing market has witnessed remarkable growth, underscoring its pivotal role in healthcare diagnostics. Valued at $265.6 million in 2021, this market is poised ...